loader2
Partner With Us NRI

Company details

4.73
5.11
2.04
8.74
6M Return 51.95%
1Y Return 146.83%
Mkt Cap.(Cr) 39.26
Volume 16,393
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 16,393

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 19.56 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 23,806.36 -39,994.59
LAST 3M 79,235.45 -52,306.79
LAST 6M 143,739.24 -201,556.99
LAST 12M 206,053.08 -176,593.86

Information

  • About Company
  • Company Info
  • Listing Info
15.75
53.86%
2.776
4.75%
2.43%
Description
  • Neocure Therapeutics (NTL) was originally a partnership firm under the name Indocure Therapeutics. It acquired Pam Industries, a sick pharmaceutical company in Dec.`85. In Sep.`87, the company was incorporated as a private limited company by taking over the partnership firm. It became a public limited company in Aug.`88. The promoters are D Krishna Kumar Raju, D Sreerama Raju and D Bharathi. The company commenced commercial operations in Nov.`87, at its factory in Hyderabad, Andhra Pradesh. During the initial years of operation, the company could not do well due to insufficient working capital funds. In 1989, the Board of Directors was reconstituted. NTL is engaged in the manufacture of liquid orals (inst. cap. : 3 lac ltr pa), tablets (inst. cap. : 1566 lac pa) and capsules (inst. cap. : 152 lac pa). The range of products of the company include anti-inflammatory, anti-pyretics, analgesics, anti bacterial and antibiotics, vitamins and paediatric products. In 1995-96, the company proposed to modernise and expand the capacity of liquid orals, tablets and capsules to 12 lac ltr pa, 6216 lac pa and 602 lac pa, respectively. It came out with a public issue in Feb.`96 to part-finance its expansion-cum-modernisation programme. The company is proposing to enter Software exports and arrangements are on with USA firm. The company is now allset to launch Natural Bio-chemicals,which occur as essential oils used in perfumery,soaps,cosmetic,mosquito repellant creams,drug industry etc.The product which will be launched in the next year are a)Citriodora b)Citronella c) Lemon Grass d) Geranium e) Japanese Mint f) Palma Rosa. As the Bio-Technology concept is growing more in the Indian Economy the company expects more scope in this area.

Read More

Registered Address

8-2-703 Mahogany Complx R No12, Amrutha Valley Banjara Hills, Hyderabad, Telangana, 500034

Tel : 91-40-66360610
Email : info:countrycondos.co.in
Website : http://www.countrycondos.co.in

Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 531624
NSE Code : COUNCODOS
Book Closure Date (Month) : Sep
BSE Group : T
ISIN : INE695B01025

ICICIdirect Country Condos Ltd FAQ

You can buy Country Condos Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Country Condos Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 20, 2022 04:01 PM the closing price of Country Condos Ltd was ₹ 5.06.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 20, 2022 04:01 PM, the market cap of Country Condos Ltd stood at ₹ 39.26.
The latest PE ratio of Country Condos Ltd as of May 20, 2022 04:01 PM is 15.75
The latest PB ratio of Country Condos Ltd as of May 20, 2022 04:01 PM is 0.56
The 52-week high of Country Condos Ltd is ₹ 8.74 while the 52-week low is ₹ 2.04 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE